Your browser doesn't support javascript.
loading
Secreted protein Del-1 regulates myelopoiesis in the hematopoietic stem cell niche.
Mitroulis, Ioannis; Chen, Lan-Sun; Singh, Rashim Pal; Kourtzelis, Ioannis; Economopoulou, Matina; Kajikawa, Tetsuhiro; Troullinaki, Maria; Ziogas, Athanasios; Ruppova, Klara; Hosur, Kavita; Maekawa, Tomoki; Wang, Baomei; Subramanian, Pallavi; Tonn, Torsten; Verginis, Panayotis; von Bonin, Malte; Wobus, Manja; Bornhäuser, Martin; Grinenko, Tatyana; Di Scala, Marianna; Hidalgo, Andres; Wielockx, Ben; Hajishengallis, George; Chavakis, Triantafyllos.
Afiliación
  • Mitroulis I; Department of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, and.
  • Chen LS; Department of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, and.
  • Singh RP; Department of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, and.
  • Kourtzelis I; Department of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, and.
  • Economopoulou M; Department of Ophthalmology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Kajikawa T; Department of Microbiology, Penn Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Troullinaki M; Department of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, and.
  • Ziogas A; Department of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, and.
  • Ruppova K; Department of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, and.
  • Hosur K; Department of Microbiology, Penn Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Maekawa T; Department of Microbiology, Penn Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Wang B; Department of Microbiology, Penn Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Subramanian P; Department of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, and.
  • Tonn T; Institute for Transfusion Medicine, German Red Cross Blood Donation Service North-East, Dresden, Germany.
  • Verginis P; Department of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, and.
  • von Bonin M; Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
  • Wobus M; Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Bornhäuser M; Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Grinenko T; Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Di Scala M; Center for Regenerative Therapies Dresden, Dresden, Germany.
  • Hidalgo A; Department of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, and.
  • Wielockx B; Area of Cell and Developmental Biology, Fundación Centro Nacional de Investigaciones Cardiovasculares (CNIC) Carlos III, Madrid, Spain.
  • Hajishengallis G; Area of Cell and Developmental Biology, Fundación Centro Nacional de Investigaciones Cardiovasculares (CNIC) Carlos III, Madrid, Spain.
  • Chavakis T; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München, Munich, Germany.
J Clin Invest ; 127(10): 3624-3639, 2017 Oct 02.
Article en En | MEDLINE | ID: mdl-28846069
ABSTRACT
Hematopoietic stem cells (HSCs) remain mostly quiescent under steady-state conditions but switch to a proliferative state following hematopoietic stress, e.g., bone marrow (BM) injury, transplantation, or systemic infection and inflammation. The homeostatic balance between quiescence, self-renewal, and differentiation of HSCs is strongly dependent on their interactions with cells that constitute a specialized microanatomical environment in the BM known as the HSC niche. Here, we identified the secreted extracellular matrix protein Del-1 as a component and regulator of the HSC niche. Specifically, we found that Del-1 was expressed by several cellular components of the HSC niche, including arteriolar endothelial cells, CXCL12-abundant reticular (CAR) cells, and cells of the osteoblastic lineage. Del-1 promoted critical functions of the HSC niche, as it regulated long-term HSC (LT-HSC) proliferation and differentiation toward the myeloid lineage. Del-1 deficiency in mice resulted in reduced LT-HSC proliferation and infringed preferentially upon myelopoiesis under both steady-state and stressful conditions, such as hematopoietic cell transplantation and G-CSF- or inflammation-induced stress myelopoiesis. Del-1-induced HSC proliferation and myeloid lineage commitment were mediated by ß3 integrin on hematopoietic progenitors. This hitherto unknown Del-1 function in the HSC niche represents a juxtacrine homeostatic adaptation of the hematopoietic system in stress myelopoiesis.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Estrés Fisiológico / Células Madre Hematopoyéticas / Proteínas Portadoras / Mielopoyesis / Nicho de Células Madre Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Clin Invest Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Estrés Fisiológico / Células Madre Hematopoyéticas / Proteínas Portadoras / Mielopoyesis / Nicho de Células Madre Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Clin Invest Año: 2017 Tipo del documento: Article